Negative symptoms in schizophrenia: Methodological challenges and emerging solutions for outcome measurement
{{output}}
Negative symptoms (NS) affect approximately 60% of individuals with schizophrenia and are associated with poor outcomes. They remain an important unmet therapeutic need, not adequately addressed by available antipsychotic drugs, and they are poorly assessed in... ...